T-Cell and NK-Cell Neoplasm — Trials

T-Cell and NK-Cell Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,103 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–50 of 205 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03380026	Mechlorethamine Induced Contact Dermatitis Avoidance Study(MIDAS)	completed	Phase 2	28	Rochester Skin Lymphoma Medical Group, PLLCOTHER	1	Sep 4, 2026	clinicaltrials
NCT05254899	A Study of Tislelizumab, Chemotherapy, and Radiation Therapy for Early-Stage High-Risk ENKTCL (CLCG-2102)(CLCG-2102)	completed	Phase 2	54	Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER